NEW YORK, Feb. 19, 2025 ( GLOBE NEWSWIRE ) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors ( the "Class" ) who purchased or acquired the securities of TransMedics Group, Inc. ( "TransMedics" or the "Company" ) TMDX between ...

Financial giants have made a conspicuous bearish move on Dutch Bros. Our analysis of options history for Dutch Bros BROS revealed 9 unusual trades. Delving into the details, we found 33% of traders were bullish, while 55% showed bearish tendencies.

Investors with a lot of money to spend have taken a bullish stance on Nebius Group NBIS. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.

The Federal Reserve on Wednesday released minutes from its January meeting.

Alibaba Group is due to release earnings tomorrow morning. There has been excessive optimism around Alibaba earnings. The stock is overbought and at resistance. Get real-time earnings alerts before the market moves and access expert analysis that uncovers hidden opportunities in the ...

VANCOUVER, British Columbia, Feb. 19, 2025 ( GLOBE NEWSWIRE ) -- Teck Resources Limited ( TSX: TECK.A and TECK.B, NYSE: TECK ) ( "Teck" ) announced today that its Board of Directors has declared an eligible dividend of $0.125 per share on its outstanding Class A common shares and Class B ...

Harmony Biosciences received an FDA Refusal to File letter for pitolisant in idiopathic hypersomnia but plans a Phase 3 trial in Q4 2025. Q4 net product revenue reached $201M, surpassing estimates, with Wakix patient count rising to 7,100, up by 300 sequentially.

BlackRock reportedly cancels meetings with companies due to new SEC rules. SEC's stricter regulations on investor activism complicate BlackRock's ability to influence corporate governance. Get real-time earnings alerts before the market moves and access expert analysis that uncovers hidden ...

PBGENE-HBV was safe and well tolerated at 0.2 mg/kg, with no serious adverse events in cohort 1 of the ELIMINATE-B trial. Two of three participants showed a substantial reduction in HBsAg after the first dose, supporting early antiviral activity.

Mullen Automotive reports a loss per share of $ ( 661.33 ) and defers revenue recognition on invoiced vehicles. Mullen Automotive implements $13M in annual cost cuts, reducing headcount and personnel expenses to improve efficiency.